The Role of Psa, Digital Rectal Examination and Transrectal Ultrasonography in Diagnosis of Prostatic Cancer

Ahmet ERBAĞCI; Faruk  YAĞCI; Tuğrul  PINAR; Kemal  SARICA

doi:10.58600/eurjther.1997-8-1-2-1488-arch

Authors

Ahmet ERBAĞCI Gaziantep Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalı
Faruk YAĞCI Gaziantep Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalı
Tuğrul PINAR Gaziantep Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalı
Kemal SARICA Gaziantep Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalı

DOI:

https://doi.org/10.58600/eurjther.1997-8-1-2-1488-arch

Keywords:

Prostatic canser, PSA, DRM, TRUS

Abstract

This study was held in Gaziantep University, School of Medicine, Department of Urology in the period of December 1992 through December 1996. Two group of patients have been included to the study; 30 prostate carcinoma and 30 benign prostate hyperplasia. Serum PSA levels werefound 10 times higher in prostate carcinoma group than BPH group. There was no statistically significant dijference between age and digital rectal examination finding with serum PSA levels of patients in both groups. Serum PSA levels and transrectal ultrasonography findings were comparedfor both group. No significant diference found between serum PSA levels and transrectal ultrasonography findings in BPH group. However, there has been statistically significant dijferences in prostate carcinoma group. When serum PSA levels and clinical stage with Gleason grade compared in prostate carcinoma group, statistically signifıcant difference was found. Although reserches are still continue to try to find the ideal test for diagnosing prostate cancer, serum PSA level is the most important parameter in early diagnosis. in this study we conclude that annual checking of serum PSA levels must be made for males over the age 50 and if it's more than 4 ng/ml, transrectal ultrasonography and biopsy must be peıformed.

Metrics

Metrics Loading ...

References

Aktaş A, Tarcan T, Türkeri L, et al: The diagnostic accuracy of digital rectal exa mination, transrectal ultrasonography, prostat specific antigen (PSA) and PSA density in prostat carsinoma. Br J Ural 76:54, 1995

Zhang G, Wasserman NF, Kapoor DA, et al: Early detection of loca[ disease prog ression from stage Al prostate carcinoma by transrectal ultrasonography. Cancer 69:2300, 1992

Imaı K, Iciınose Y, Kubata Y, et al: Diagnostic significance of prostate specific antigen and the development of a mass screening far prostate cancer J Ural 154:1085, 1995

Oesterling JE, Jacobsen SJ , Klee GG, et al: Free, complexed and total serum pros tate specific antigen: The estabilishment of appropriate reference ranges far their con centrations and ratios. J Ural 154: 1090, 1995

Fitzpatrick P, Corcoran N, Fitzpatrick JM: Prostate cancer: How aware is the pablic Br J Urol 82:43, 1998

Cooner WH, Mosley BR, Rutheıford CL, et al: Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer. J Ural 139:758, 1988

Chen Y, Luderer AA, Thiel RP, et al: Using proportions of free to total prostate specific antigen, age and total prostate specific antigen to predict the probability of prostate cancer. Urology 47:518, 1996

Türkeri L, Tarcan T, Biren, et al: Transrectal ultrasonography versus digi tally guided prostate biopsies in patients with palpable lesions on digital rectal examination. Br J Ural 76:184, 1995

Catalona WJ, Richie JP, Ahmann, et al: Comparison of rectal examination and se rum prostate specific antigen in early detection of prostate carcinoma: Results of a multicenter clinical trial of 6630 men. J Ural 151:1283,1994

O. Brawer MK, Chetner MP, Beatie J, et al: Screening for prostatic carcinoma with prostate specific antigen. J Ural 147:841, 1992

Cooner WH, Mosley BR, Ruthe,ford Cl, et al: Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostat spe cific antigen. J Ural 143:1146, 1990

Stamey TA, McNeal LE: Adenocarcinoma of prostate in: Campbell's Urology, chapter 29. Walsh PC, Retik AB, Stamy TA, Vaughan ED (ed). Pennssylvania: saunders company, [992 Ed 6, p ll59

Elgama A, Cornillie FJ, VanPoppel HP, et al: Free to total prostate specific antigen ratio as a single test for detection of significant stage Tlc prostate cancer. J Ural 156:1042, 1996

Hagood PG, Parra RO, Rauscher JA: Nontraumatic elevation of prostate specific antigen following cardiac surgery and extracorporeal cardiopulmonary by pass. J Ural 152:2043,1994

Oesterling JE: Prostat specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Ural 145:907, 1991

Stamy TA, Kabalin JN: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. J Ural 141:1070, 1989

Stamey TA, Kabalin JN: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. 1. Untreated Patients. J Ural l41:1070,1989

Ellis WJ, Chetner MP, Preston SD, et al: Diagnosis of prostatic carcinoma: The yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. J Ural 152:1520, 1994

Aktaş A, Tarcan T, Türkeri L, et al: The diagnostic accuracy of digital rectal examination, transrectal ultrasonography, prostate specific antigen (PSA) and PSA density in prostate carcinoma. Br J Ural 76:54,1995

Nadler RB, Humphrey P, Smith DS, et al: Ejfect of imflammation and benign prosta tic hyperplasia on elevated serum prostate specific antigen levels. J Ural 154:407, 1995

Benson MC, Wang JS, Olsson CA, et al: The use of prostate specific antigen density to enhance the predictive value of interme diate levels of serum prostate specific antigen. J Urol 147: 817,1992

Akdaş A, Dillioğlu Ö, Çevik İ, et al: lmpact of prostate specific antigen density in benign prostatic hyperplasia and prostatic cancer. Eur Urol 25:299, 1994

Brawer MK: The diagnosis of prostatic carcinoma. Cancer 71:899, 1993

Cooner WH, Mosley BR, Rutherford Cl, et al: Clinical application of transrectal ultrasonography and prostate specific antigen in the searchfor prostate cancer. J Ural 139:758, 1988

Lee F, Gray JM, Mcleary RD, et al: Pros tatic evaluation by transrectal sono graphy: Criteria for diagnosis of early carcinoma. Radiology 158:91, 1986

Lee F, Littrup PJ, Christensen LL, et al: Predicted prostate specifıc antigen results using transrectal ultrasound gland volume. Cancer 70:211, 1992

Carter HB, Hamper UM, Sheth S, et al: Evaluation of transrectal ultrasound in the early detection of prostate cancer. J Ural 142:1008, 1989

Simak R, Eisenmenger M, Hainz A, et al: Is transrectal ultrasonography needed to rule out prostatic cancer with normal findings at digital rectal examination and normal serum prostate specific antigen. Eur Urol 24:474, 1993

Türkeri L, Tarcan T, Biren T, et al: Transrectal ultrasonography versus digi tally guided prostate biopsies in patients with palpable lesions on digital rectal examination. Br J Urol 76:184,1995